Orlistat, commonly known by the brand name Xenical, is a peripherally acting antiobesity agent designed to inhibit fat absorption from the diet. It works by blocking pancreatic and gastric lipases, enzymes that break down triglycerides, thereby reducing calorie intake[3].
The global Orlistat market has demonstrated its significant growth potential. As of 2023, the market size was valued at USD 970.53 million and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.5% from 2024 to 2027. By 2031, the market is expected to reach approximately USD 3 billion, growing at a CAGR of at least 8.5% from 2024 to 2031[1].
The market isNorth America and is expected to grow at a Compound annual growth rate of nearly 20% from 2024 to 2031. The Asia Pacific region, particularly Asia Pacific member states due to their fattening and obesity policies, for example, Asia Pacific is known for obesity rates during the hypocaloric era, a bubble that persists into the new century. The market is also segmented by region, with Asia Pacific being a key driver of growth[1][3].
Europe is also a key market for Orlistat, with a Compound annual growth rate of approximately 20% in the former Soviet Union. The region's fattening and obesity policies are also key drivers, with the increasing prevalence of obesity in the post-World War II years and the growing popularity of weight management solutions among healthcare professionals[3].
The global Orlistat market is driven by several key factors:
The market size was valued at USD 9,100.54 million in 2023 and is projected to grow at a Compound annual growth rate of 8.5% from 2024 to 2031[3].
The Asia Pacific region is the key market for Orlistat, with a Comp annual growth rate of 8.5%.
The market is projected to grow at a Comp constant rate of 8.5% during the forecast period, with a CAGR of approximately 8.5% from 2024 to 2031[1].
Orlistat is available in various pharmacies and healthcare facilities, with pharmacies being the most common location for medication.[3][4].
The main drivers include increasing incidence of obesity, growing awareness of obesity patients, and growing prevalence of obesity. However, the Asia Pacific region is the key driver of the market, with a CAGR of 8.5% in 2022[1].
You can buy Orlistat (Xenical/Alli) as an over-the-counter alternative to Wegovy in the UK.
However, Orlistat is a very different type of weight-loss medication, and research suggests it’s not as effective as Wegovy in supporting weight loss.
Wegovy and Orlistat are weight-loss medications approved for use in the UK. However, they are different medications with distinct dosing schedules, costs, and mechanisms of action on the body.
Orlistat is a lipase inhibitor. Lipases are gut enzymes that break down fat from food, enabling the gut to transport fat into the body to be burnt for energy or stored in our fat cells for later use.
Orlistat blocks lipases, preventing some of the dietary fat from our meals from being digested. This leads to fewer calories being absorbed, which can support weight loss.
Orlistat is a prescription medication produced by two pharmaceutical companies in the UK:
Wegovy is a weight-loss jab manufactured by Novo Nordisk. It’s a weekly weight-loss injection with semaglutide as the active ingredient.
Semaglutide is a that helps reduce hunger and appetite, allowing you to eat fewer calories, lose weight, and manage your blood sugar levels.
Wegovy is approved in the UK for individuals living with obesity to help them eat fewer calories and lose weight.
The over-the-counter version of Orlistat will cost around £18 a month, so it’s a very affordable medication.
In comparison, buying Wegovy and the injectable pens required for four weeks from Second Nature will cost £229 a month, rising to £299.
Orlistat is an affordable medication that is generally well-tolerated. However, it’s less effective than Wegovy. Wegovy is twice as effective as Orlistat for weight loss after one year.
So, if you’re looking for the most affordable weight-loss pill you can purchase over the counter, then Orlistat could be an option.
However, if you have a higher budget and are looking for the most effective weight-loss injection in the UK, semaglutide is a better choice.
Semaglutide is designed as an additional tool for weight management and, in most cases, shouldn’t be considered a lifelong medication.
Instead, it should be used to help you kickstart your weight loss and healthy journey while you commit to living a healthier lifestyle.
Ideally, we’d be able to lose weight without medication and lifestyle changes would be enough to support weight loss in the long term.
We’d generally recommend trying Second Nature’s before considering a weight-loss jab.
Changing your habits is the most sustainable way to achieve long-term weight loss, and it’s also less expensive.
At Second Nature, we’ve been trusted by the NHS since 2017 to support people with type 2 diabetes and obesity to lose weight, manage their blood sugar levels, and lead healthier lifestyles for the long term.
In 2022, the NHS in the BMJ that compared the weight loss outcomes of five providers in the National Diabetes Prevention Programme.
Second Nature was more than twice as effective at supporting weight loss than the other four providers.
However, if you’ve decided to try semaglutide (when it’s available) but need support in making positive changes to your lifestyle, Second Nature could be an option for you. But it’s worth noting that we have strict eligibility criteria.
Second Nature has been approved for use in the UK within a few months of being recommended by the NHS.In 2022, Second Nature led the global weight loss journey, comparing the weight loss outcomes of five providers in the National Diabetes Prevention Programme.
Orlistat is used to treat obesity and help in weight loss. Orlistat is to be used along with a low-calorie diet and regular physical exercise. Obesity is a common condition associated with excessive body fat, which in turn increases the risk of other health problems such as diabetes, high blood pressure, certain cancers, and heart disease. Intake of more calories than you burn by exercise or daily activities results in obesity.
Orlistat contains Orlistat, which works in the small intestine and stomach and prevents the action of enzymes that break down fat, which is absorbed by the body. Orlistat decreases the absorption of fat from the food you eat. Thus, fat passes through the gut and is excreted in the faeces, which makes the body unable to use fat as a source of energy or convert it into fat tissue. Thereby, Orlistat helps in weight loss.
Take Orlistat as prescribed by your doctor. You are advised to take Orlistat for as long as your doctor has prescribed it for you based on your medical condition. Some people may experience soft stools, sudden bowel motions, flatulence (gas) with or without oily spotting, oily or fatty stools, stomach pain, stool incontinence (involuntary leakage of stools), and runny or liquid stools. Most of these side effects of Orlistat do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor.
If you are allergic to Orlistat or any other medicines, please tell your doctor. Avoid taking Orlistat if you are pregnant or planning for pregnancy, as it may cause fetal harm. It is not known whether Orlistat is excreted in human milk. Therefore, please consult a doctor if you are a breastfeeding woman. Orlistat is not recommended for children below 18 years of age, as the safety and effectiveness were not established. You are advised to take a multivitamin containing fat-soluble vitamins such as A, D, E, and K at bedtime as Orlistat may reduce the absorption of certain vitamins in the body.
The most common side effects of Orlistat are flushing, headache, dizziness, nausea, diarrhoea, wind, and stomach upset. If any of these side effects persist consult your doctor.Male pattern baldness
B frontal hair loss is the most common hair loss condition associated with Orlistat. It causes a sudden loss of hair along with a variety of hair growth problems, including thinning, a change in the hair growth phase, and an increase in the hair loss volume. Because of the sudden loss of hair, the hair growth is stopped and the condition improved. Orlistat may affect the pattern of hair loss by causing a lack of growth in areas affected by hair loss, increasing hair loss, or both.
Other possible side effects of Orlistat are constipation, dizziness, sleepiness, blurred vision, and muscle cramps. If any of these side effects bother you, please consult your doctor. Orlistat can increase the level of fat in the blood, which may cause low blood levels of potassium, calcium, magnesium, or other nutrients required for bone and muscle growth.
Patients taking Orlistat may experience the following symptoms:
If you experience any of the above symptoms and you are taking Orlistat, please consult a doctor. Also, if you have any doubts about the cause of the hair loss, please tell your doctor. Orlistat may cause weight loss because it reduces the absorption of fat-soluble vitamins, which are necessary for the body to use nutrients. Therefore, you are advised to take a multivitamin containing fat-soluble vitamins such as A, D, E, and K at bedtime. You can find more information on this on the links page of the drug.
ALCOHOL
Orlistat is a prescription medicine. Please consult a doctor or pharmacist for professional advice.
Also, you are being asked to pay only a small attention to the eye. Rest of the vision is due to the action of an enzyme called 5-alpha-reductase. This enzyme converts or Eliminin-methyl groups to Dutasteride, which is a drug to prevent the absorption of dietary fats.Baijiu, Fujian Province, July 20, 2018 (GLOBE NEWSWIRE) -- Biotec Global Services, Inc. (BSI) is the principal producer of the Orlistat 120mg Capsules, manufactured by Biotec Pharmaceuticals, Ltd., a leading global pharmaceutical company. Biotec’s portfolio of over 20 products are sold worldwide by the pharmaceutical company and by BSI. Biotec, with more than 10 years experience in the production of pharmaceuticals and other pharmaceutical products, is the only company to have produced a generic version of Orlistat 120mg Capsules and Biotec’s branded product is Orlistat 120mg Capsules. Biotec is known for its commitment to the development of new pharmaceutical products, as well as the manufacture of pharmaceutical products. In addition to its role in developing new pharmaceutical products, BSI’s commitment to the development of new pharmaceutical products contributes to the continued innovation and commercialization of Biotec’s products, including the development of new pharmaceutical products. Biotec is committed to the development of the pharmaceutical industry by working with the pharmaceutical and biotechnology companies to develop, market, and produce the pharmaceutical products they are producing. This commitment to the development of pharmaceutical products is a testament to the company’s commitment to the development of new pharmaceutical products and its commitment to the production of pharmaceuticals. BSI is a leading global pharmaceutical company with a strong focus on the development of pharmaceutical products in the United States and worldwide.
About Biotec Pharmaceuticals
Biotec Pharmaceuticals is a leading manufacturer of over 20 products in over 20 countries. Its innovative pharmaceutical products are manufactured in the United States, Europe, Asia Pacific, Latin America, and other countries. Biotec’s portfolio of more than 20 products includes over 500 medicines. Biotec is known for its commitment to the development of new pharmaceutical products and its commitment to the production of pharmaceutical products. BSI is a leading global pharmaceutical company with a strong focus on the development of new pharmaceutical products. BSI is known for its commitment to the development of new pharmaceutical products and its commitment to the production of pharmaceutical products.
Stade de France Pharmacy